DESCRIPTION OF PREFERRED
STOCK
As of the date of this prospectus, the authorized capital stock of
Ally Financial Inc. consists of 1,400,000,000 shares of capital
stock, of which 1,100,000,000 shares are shares of common stock,
$0.01 par value per share, and 300,000,000 shares are shares of
preferred stock, $0.01 par value per share, issuable in series.
As of November 1, 2019, 380,068,995 shares of common stock
were issued and outstanding. No shares of preferred stock were
issued and outstanding as of September 30, 2019.
To the extent authorized, we may issue preferred stock under the
currently existing series of preferred stock. In addition, we may
issue new series of preferred stock.
The following discussion of the material provisions of the
preferred stock, Ally’s Amended and Restated Certificate of
Incorporation and Bylaws are qualified in their entirety by
reference to such Amended and Restated Articles of Incorporation
and Bylaws, copies of which have been incorporated by reference as
exhibits to the registration statement of which this prospectus
forms a part.
Ally may issue shares of preferred stock in one or more series,
either separately, or together with, or upon the conversion of or
in exchange for, other securities. When Ally offers to sell a
particular series of preferred stock, Ally will describe the
specific terms of such preferred stock in a supplement to this
prospectus. The preferred stock will be issued under a certificate
of designation, which forms, or will form, a part of Ally’s Amended
and Restated Certificate of Incorporation at the time such
preferred stock is issued. The form of articles of amendment
relating to the certificate of designation of a series of preferred
stock will be incorporated by reference in the registration
statement of which this prospectus forms a part. The terms of the
preferred stock offered by any prospectus supplement may differ
from the general terms set forth in this prospectus.
If Ally offers preferred stock, the terms of any particular series
of preferred stock, including preferred stock to be represented by
depositary shares, will be described in the applicable prospectus
supplement, including (where applicable) the voting rights (if
any), designations, powers, preferences, and the relative,
participating, optional or other rights (in each case, if any), and
the qualifications, limitations, or restrictions of any unissued
series of preferred stock. The applicable prospectus supplement
will also describe any restrictions to which the preferred stock
being offered will be subject pursuant to the terms of Ally’s
then-outstanding capital stock.
The issuance of preferred stock, while providing flexibility in
connection with possible acquisitions and other corporate purposes,
could, among other things, adversely affect the voting power of the
holders of common stock and, under certain circumstances, make it
more difficult for a third party to gain control of Ally or to
remove present management and could have the effect of delaying or
preventing a merger, tender offer or other attempted takeover of
Ally. No holder of preferred stock will be entitled, as a matter of
right, to subscribe for or purchase any shares of preferred stock
or common stock.
Any preferred stock that we issue will, when issued, be fully-paid
and non-assessable. Unless
otherwise specified in the applicable prospectus supplement, any
series of offered preferred stock will rank, with respect to
dividends and the distribution of assets, senior to common stock,
and on a parity with shares of any other then outstanding series of
preferred stock. Therefore, any preferred stock that may
subsequently be issued may limit the rights of the holders of our
common stock and preferred stock. In addition, under certain
circumstances, preferred stock could also restrict dividend
payments to our holders of common stock.
The transfer agent and registrar for a series of preferred stock
will be named in the applicable prospectus supplement.
17